-
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 26/12/24 )
NAV
₹30.94
Last change
₹0.07 +0.0%
Fund Size (AUM)
1213.92 Cr
Performance
27.54% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
as of 26/12/24
AUM
1213.92 Cr
Expense Ratio
2.14 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K018A5
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl | 40.0% | 21.9% | 27.54% |
| Nifty Pharma TR INR | 43.76% | 19.63% | 26.27% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.8% |
Aurobindo Pharma Ltd |
7.71% |
Lupin Ltd |
6.93% |
Cipla Ltd |
6.19% |
Dr Reddy's Laboratories Ltd |
6.09% |
Divi's Laboratories Ltd |
5.34% |
Fortis Healthcare Ltd |
4.64% |
Zydus Lifesciences Ltd |
3.75% |
Alkem Laboratories Ltd |
3.5% |
Apollo Hospitals Enterprise Ltd |
3.31% |
Sector Allocation
Healthcare |
97.73% |
Basic Materials |
2.27% |
Asset Allocation
-
96%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
30.45% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
27.59% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
29.42% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
29.42% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-P
Equity healthcare-
Returns
-
29.42% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
27.54% (5Y)
-
